Boosting antimicrobial activity of ciprofloxacin by functionalization of mesoporous silica nanoparticles

Mesoporous silica nanoparticles (MSNs) are very promising nanomaterials for treating bacterial infections when combined with pharmaceutical drugs. Herein, we report the preparation of two nanomaterials based on the immobilization of ciprofloxacin in mesoporous silica nanoparticles,either as the coun...

ver descrição completa

Detalhes bibliográficos
Autor principal: Mora, Blanca de Juan (author)
Outros Autores: Filipe, Luís (author), Forte, Andreia (author), Santos, Miguel M. (author), Alves, Celso (author), Teodoro, Fernando (author), Pedrosa, Rui (author), Ribeiro Carrott, Manuela (author), Branco, Luís C. (author), Gago, Sandra (author)
Formato: article
Idioma:eng
Publicado em: 2021
Assuntos:
Texto completo:http://hdl.handle.net/10174/29114
País:Portugal
Oai:oai:dspace.uevora.pt:10174/29114
Descrição
Resumo:Mesoporous silica nanoparticles (MSNs) are very promising nanomaterials for treating bacterial infections when combined with pharmaceutical drugs. Herein, we report the preparation of two nanomaterials based on the immobilization of ciprofloxacin in mesoporous silica nanoparticles,either as the counter-ion of the choline derivative cation MSN-[Ch][Cip]) or via anchoring on the surface of amino-group modified MSNs via an amide bond (MSN-Cip). Both nanomaterials were characterized by TEM, FTIR and solution 1H NMR spectroscopies, elemental analysis, XRD and N2 adsorption at 77 K in order to provide the desired structures. No cytotoxicity from the prepared mesoporous nanoparticles on 3T3 murine fibroblasts was observed. The antimicrobial activity of the nanomaterials was determined against Gram-positive (Staphylococcus aureus and Bacillus subtilis) and Gram-negative (Klebsiella pneumoniae) bacteria and the results were promising against S. aureus. In the case of B. subtilis, both nanomaterials exhibited higher antimicrobial activity than the precursor [Ch][Cip], and in the case of K. pneumoniae they exhibited higher activity than neutral ciprofloxacin.